Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 54 Records) |
| Query Trace: Recurrence and FGFR3[original query] |
|---|
| Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis. Neoplasma 2016 63 (6): 952-960. Traczyk-Borszynska M, Borkowska E, Jablonowski Z, Jedrzejczyk A, Pietrusinski M, Kaluzewski B, Sosnowski M, Borowiec |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma. Human pathology 2016 May . Li Chengfang, Shen Yaoyuan, Ren Yan, Liu Wei, Li Man, Liang Weihua, Liu Chunxia, Li Fe |
| The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients. Oncotarget 2016 Mar . Yuan Xiaotian, Liu Cheng, Wang Kun, Liu Li, Liu Tiantian, Ge Nan, Kong Feng, Yang Liu, Björkholm Magnus, Fan Yidong, Zhao Shengtian, Xu Daw |
| Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer. Oncotarget 2016 Feb . Iacono Marco Lo, Buttigliero Consuelo, Monica Valentina, Bollito Enrico, Garrou Diletta, Cappia Susanna, Rapa Ida, Vignani Francesca, Bertaglia Valentina, Fiori Cristian, Papotti Mauro, Volante Marco, Scagliotti Giorgio V, Porpiglia Francesco, Tucci Marcel |
| Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential. Histopathology 2017 Nov . Wang Chung-Chieh, Huang Chao-Yuan, Jhuang Yu-Lin, Chen Chih-Chi, Jeng Yung-Mi |
| Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing. Digestive diseases and sciences 2017 1 62 (2): 407-417. Yan Xiaopeng, Shao Cong, Chen Chuang, Chen Jun, Gu Shen, Huang Luoshun, Fu Xu, Zhao Hui, Qiu Yudo |
| Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer. European urology 2017 1 71 (6): 961-969. Christensen Emil, Birkenkamp-Demtröder Karin, Nordentoft Iver, Høyer Søren, van der Keur Kirstin, van Kessel Kim, Zwarthoff Ellen, Agerbæk Mads, Ørntoft Torben Falck, Jensen Jørgen Bjerggaard, Dyrskjøt La |
| CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific reports 2018 9 8 (1): 14383. Worst Thomas S, Weis Cleo-Aron, Stöhr Robert, Bertz Simone, Eckstein Markus, Otto Wolfgang, Breyer Johannes, Hartmann Arndt, Bolenz Christian, Wirtz Ralph M, Erben Phili |
| Interest of next-generation sequencing in BCG-treated high-risk bladder cancer. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018 4 28 (6): 344-350. Jungels C, Martinez Chanza N, Albisinni S, Mercier M, d'Haene N, Rorive S, Roumeguère |
| Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (3): 967-976. Audenet François, Isharwal Sumit, Cha Eugene K, Donoghue Mark T A, Drill Esther N, Ostrovnaya Irina, Pietzak Eugene J, Sfakianos John P, Bagrodia Aditya, Murugan Paari, Dalbagni Guido, Donahue Timothy F, Rosenberg Jonathan E, Bajorin Dean F, Arcila Maria E, Hechtman Jaclyn F, Berger Michael F, Taylor Barry S, Al-Ahmadie Hikmat, Iyer Gopa, Bochner Bernard H, Coleman Jonathan A, Solit David |
| SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
| Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. International journal of cancer 2019 5 145 (11): 3152-3162. Dogan Snjezana, Xu Bin, Middha Sumit, Vanderbilt Chad M, Bowman Anita S, Migliacci Jocelyn, Morris Luc G T, Seshan Venkatraman E, Ganly I |
| Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. BJU international 2019 May . Ward Douglas G, Gordon Naheema S, Boucher Rebecca H, Pirrie Sarah J, Baxter Laura, Ott Sascha, Silcock Lee, Whalley Celina M, Stockton Joanne D, Beggs Andrew D, Griffiths Mike, Abbotts Ben, Ijakipour Hanieh, Latheef Fathimath N, Robinson Robert A, White Andrew J, James Nicholas D, Zeegers Maurice P, Cheng K K, Bryan Richard |
| New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses. Oncotarget 2019 10 10 (53): 5549-5559. AlSahlawi Aysha, Aljelaify Rasha, Magrashi Amna, AlSaeed Mariam, Almutairi Amal, Alqubaishi Fatimah, Alturkistani Abdulellah, AlObaid Abdullah, Abouelhoda Mohamed, AlMubarak Latifa, AlTassan Nada, Abedalthagafi Mal |
| Clinical Validation of a Urine Test (Uromonitor-V2) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients. Diagnostics (Basel, Switzerland) 2020 9 10 (10): . Sieverink Caroline A, Batista Rui P M, Prazeres Hugo J M, Vinagre João, Sampaio Cristina, Leão Ricardo R, Máximo Valdemar, Witjes J Alfred, Soares Pau |
| Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. European urology 2020 8 78 (6): 907-915. Teo Min Yuen, Mota Jose Mauricio, Whiting Karissa A, Li Han A, Funt Samuel A, Lee Chung-Han, Solit David B, Al-Ahmadie Hikmat, Milowsky Matthew I, Balar Arjun V, Pietzak Eugene, Dalbagni Guido, Bochner Bernard H, Ostrovnaya Irina, Bajorin Dean F, Rosenberg Jonathan E, Iyer Go |
| Molecular investigation of FGFR3 gene mutation and its correlation with clinicopathological findings in Indian bladder cancer patients. Cancer reports (Hoboken, N.J.) 2020 7 1 (3): e1130. Ahmad Firoz, Mahal Vishal, Verma Geeta, Bhatia Simi, Das Bibhu Ranj |
| Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer. Frontiers in oncology 2020 10 755. Hayashi Yujiro, Fujita Kazutoshi, Matsuzaki Kyosuke, Eich Marie-Lisa, Tomiyama Eisuke, Matsushita Makoto, Koh Yoko, Nakano Kosuke, Wang Cong, Ishizuya Yu, Kato Taigo, Hatano Koji, Kawashima Atsunari, Ujike Takeshi, Uemura Motohide, Imamura Ryoichi, Netto George J, Nonomura Nor |
| Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer. Scientific reports 2020 10 10 (1): 16641. Le Goux Constance, Vacher Sophie, Schnitzler Anne, Barry Delongchamps Nicolas, Zerbib Marc, Peyromaure Michael, Sibony Mathilde, Allory Yves, Bieche Ivan, Damotte Diane, Pignot Geraldi |
| Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse. Expert review of molecular diagnostics 2020 10 20 (11): 1149-1159. Cho William C S, Tse Ka-Po, Ngan Roger K C, Cheuk Wah, Ma Victor W S, Yang Yi-Ting, Yip Timothy T C, Tan Kien Thiam, Chen Shu-J |
| Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis. European urology open science 2020 Oct 21 61-68. Khalid Sidra, Basulaiman Bassam Mohammed, Emack Jeffrey, Booth Christopher M, Duran Ignacio, Robinson Andrew G, Berman David, Smoragiewicz Martin, Amir Eitan, Vera-Badillo Francisco |
| Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 6 27 (16): 4599-4609. Damrauer Jeffrey S, Roell Kyle R, Smith Markia A, Sun Xuezheng, Kirk Erin L, Hoadley Katherine A, Benefield Halei C, Iyer Gopakumar, Solit David B, Milowsky Matthew I, Kim William Y, Nielsen Matthew E, Wobker Sara E, Dalbagni Guido, Al-Ahmadie Hikmat A, Olshan Andrew F, Bochner Bernard H, Furberg Helena, Troester Melissa A, Pietzak Eugene |
| Significance of KDM6A mutation in bladder cancer immune escape. BMC cancer 2021 5 21 (1): 635. Chen Xingxing, Lin Xuehua, Pang Guofu, Deng Jian, Xie Qun, Zhang Zhengro |
| Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. Urologic oncology 2021 3 39 (7): 409-421. Kardoust Parizi Mehdi, Margulis Vitaly, Lotan Yair, Mori Keiichiro, Shariat Shahrokh |
| SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer. European urology open science 2021 12 34 59-67. Lindgren Maria Skydt, Lamy Philippe, Lindskrog Sia Viborg, Christensen Emil, Nordentoft Iver, Birkenkamp-Demtröder Karin, Ulhøi Benedicte Parm, Jensen Jørgen Bjerggaard, Dyrskjøt La |
| Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing. Cancer cell international 2021 Jan 21 (1): 23. Shao Yanxiang, Hu Xu, Yang Zhen, Lia Thongher, Yang Weixiao, Wu Kan, Ren Shangqing, Xiong Sanchao, Dou Weichao, Feng Shuyang, Wang Yaohui, Liu Yang, Wu Kang, Li Xia |
| Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma. Virchows Archiv : an international journal of pathology 2022 Jun . Yamashita Atsushi, Suehara Yoshiyuki, Hayashi Takuo, Takagi Tatsuya, Kubota Daisuke, Sasa Keita, Hasegawa Nobuhiko, Ishijima Muneaki, Yao Takashi, Saito Tsuyos |
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers. Frontiers in oncology 2022 12 819555. Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: